P2Y(12) inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials

AIM: To compare the efficacy and safety of P2Y(12) inhibitor or aspirin monotherapy for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD). METHODS AND RESULTS: Medline, Embase, and Cochrane Central databases were searched to identify randomized trials comparing mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Devika, Bhatia, Kirtipal, Chunawala, Zainali S, Furtado, Remo H M, Mukherjee, Debabrata, Dixon, Simon R, Jain, Vardhmaan, Arora, Sameer, Zelniker, Thomas A, Navarese, Eliano P, Mishkel, Gregory J, Lee, Cheong J, Banerjee, Subhash, Bangalore, Sripal, Levisay, Justin P, Bhatt, Deepak L, Ricciardi, Mark J, Qamar, Arman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242055/
https://www.ncbi.nlm.nih.gov/pubmed/35919116
http://dx.doi.org/10.1093/ehjopen/oeac019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242055/
https://www.ncbi.nlm.nih.gov/pubmed/35919116
http://dx.doi.org/10.1093/ehjopen/oeac019

Ejemplares similares